Gender of pediatric recombinant human growth hormone recipients in the United States and globally

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2050-2056

  Grimberg, Adda ^a,c   Stewart, Elizabeth ^b   Wajnrajch, Michael P ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Pfizer Global Pharmaceuticals   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; ASIA; AUSTRALIA; BODY HEIGHT; CHILD; CONTROLLED STUDY; DRUG INDICATION; DRUG SAFETY; DRUG USE; ECONOMIC EVALUATION; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; GROWTH HORMONE DEFICIENCY; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH STATUS; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; POPULATION SIZE; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; TREATMENT OUTCOME; UNITED STATES;

EID: 45149134200     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2617     Document Type: Article

References (27)

1. August GP, Lippe BM, Blethen SL, Rosenfeld RG, Seelig SA, Johanson AJ, Compton PG, Frane JW, McClellan BH, Sherman BM 1990 Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. J Pediatr 116:899-903
2. Lippe BM 1992 Growth hormone treatment: does ascertainment bias determine treatment practices? Growth Genet Horm 8(Suppl 1):31-34
3. Chatelain P 1999 Trends in the diagnosis and treatment of short stature as revealed by KIGS. In: Ranke MB, Wilton P, eds. Growth hormone therapy in KIGS: 10 years' experience. Heidelberg: Barth; 1-20
4. US Census Bureau 2000 United States Census 2000. http://www.census.gov/main/www/cen2000.html
5. Lindstrom C, Lindstrom M 2006 "Social capital," GNP per capita, relative income, and health: an ecological study of 23 countries. Int J Health Serv 36:679-696
6. World Health Organization Highlights on health. http://www.who.int/countries/en (accessed 2007)
7. Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB 2007 Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 143:443-448
8. Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB 2004 Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr 145:744-749
9. l'Allemand D, Eiholzer U, Schlumpf M, Steinert H, Riesen W 2000 Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome. Eur J Pediatr 159:835-842
10. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR 2002 Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450-455
11. Grimberg A, De Leon D 2005 Disorders of growth. In: Moshang Jr T, ed. Pediatric endocrinology: the requisites in pediatrics. St. Louis: Elsevier Mosby; 127-167
12. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M 1994 Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 125:29-35
13. Stochholm K, Gravholt CH, Laursen T, Jørgensen JO, Laurberg P, Andersen M, Kristensen LØ, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A 2006 Incidence of GH deficiency - a nationwide study. Eur J Endocrinol 155:61-71
14. Gravholt CH 2005 Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 1:41-52
15. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH 2006 Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91:3897-3902
16. Gravholt CH, Juul S, Naeraa RW, Hansen J 1996 Prenatal and postnatal prevalence of Turner's syndrome: a registry study. BMJ 312:16-21
17. Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR 2006 Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature. Arch Pediatr Adolesc Med 160:263-269
18. US Food and Drug Administration 2003 FDA approves Humatrope for short stature. www.fda.gov/bbs/topics/ANSWERS/2003/ANS01242.html
19. Growth Hormone Research Society 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 85:3990-3993
20. Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, Rodbard HW, Seibel JA, Vance ML, Zimmerman D, Palumbo PJ, Bergman DA, Garber JR, Hamilton Jr CR, Petak SM, Rettinger HI, Service FJ, Shankar TP, Stoffer SS, Tourletot JB, American Association of Clinical Endocrinologists Growth Hormone Task Force 2003 American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocr Pract 9:65-75
21. Chihara K 2005 Diagnosis guideline for pediatric growth hormone deficiency. In: Study Report for Pituitary Dysfunction. Tokyo, Japan: Japan Ministry of Health, Labour and Welfare. 118-120
22. Hall DM 2000 Growth monitoring. Arch Dis Child 82:10-15
23. National Screening Committee 2004 Child health sub-group report-growth disorders. Leeds: National Screening Committee. http://www.library.nhs.uk/screening/ViewResource.aspx?resID=61017
24. National Institute for Clinical Excellence 2005 Guidance on the use of human growth hormone (somatropin) in children with growth failure. Technology Appraisal Guidance No. 42, 1-19
25. Cuttler L, Silvers JB, Singh J, Marrero U, Finkelstein B, Tannin G, Neuhauser D 1996 Short stature and growth hormone therapy. A national study of physician recommendation patterns. JAMA 276:531-537
26. Grimberg A, Kutikov JK, Cucchiara AJ 2005 Sex differences in patients referred for evaluation of poor growth. J Pediatr 146:212-216
27. Hall SS 2006 Size matters: how height affects the health, happiness, and success of boys-and the men they become. Boston: Houghton Mifflin Co.